bucladesine has been researched along with talipexole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, SG; Ong, ML; Vaughan, PF | 1 |
| Kakimura, JI; Kitamura, Y; Kohno, Y; Kosaka, T; Matsuoka, Y; Nomura, Y; Taniguchi, T | 1 |
2 other study(ies) available for bucladesine and talipexole
| Article | Year |
|---|---|
Regulation of noradrenaline release from rat occipital cortex tissue chops by alpha 2-adrenergic agonists.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Brimonidine Tartrate; Bucladesine; Clonidine; Colforsin; Cyclic AMP; Histological Techniques; Male; Norepinephrine; Occipital Lobe; Quinoxalines; Rats; Rats, Inbred Strains | 1991 |
Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.
Topics: 1-Methyl-4-phenylpyridinium; Antiparkinson Agents; Apoptosis; Azepines; Benzothiazoles; Bromocriptine; Bucladesine; Caspase 3; Caspases; Dopamine Agonists; Humans; Pramipexole; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |